Test Price
2,800 AED✅ Home Collection Available
FLNA Gene Otopaladigital Syndrome Type 1 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Next‑Generation Sequencing with full FLNA gene coverage.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance by a Consultant Medical Geneticist for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
- Corporate Lab: DNA Labs UAE – DHA Facility License No. 1143.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test interrogates the entire coding region of the FLNA gene to identify pathogenic variants causing Otopaladigital syndrome type 1, a rare X‑linked dominant disorder characterized by craniofacial dysmorphism, skeletal dysplasia, and conductive hearing loss.
The assay provides comprehensive coverage of all exons and flanking intronic regions, ensuring detection of single nucleotide variants, small insertions/deletions, and copy number variations.
| Feature | Our Test (FLNA NGS) | Closest Alternative (Sanger Hotspot) |
|---|---|---|
| Methodology | Full‑gene NGS (Next‑Generation Sequencing) | Targeted Sanger sequencing of few exons |
| Analytical Sensitivity | >99.9% for nucleotide substitutions and small indels | ~90% for tested hotspots only |
| Turnaround Time | 3–4 Weeks | 1–2 Weeks (limited scope) |
| Price (AED) | 2,800 | ~1,500–2,000 |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recognize the profound clinical value of this FLNA gene test; it clarifies the molecular basis for families and guides targeted management. I always advise correlating results with detailed phenotyping and never altering treatment without expert review.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Precautions
- Pre‑test genetic counseling is strongly recommended to discuss implications of results for the patient and family members.
- Informed consent must be obtained prior to sample collection, especially for predictive testing in minors.
- Results should be interpreted in conjunction with a thorough clinical evaluation and family history.
Exclusion Criteria
- Active bleeding disorder or coagulopathy unsuitable for venipuncture.
- Lack of informed consent or prior genetic counseling when required.
- Emergency red flags such as sudden hearing loss, respiratory distress, or palatal dysfunction require immediate medical evaluation and are not suitable for routine testing.
Patient FAQ & Clinical Guidance
1. What is the diagnostic accuracy of this FLNA test?
The FLNA NGS test provides greater than 99% analytic sensitivity and specificity, ensuring near‑complete detection of pathogenic DNA variants in the gene.
2. How should I prepare for the blood draw at home?
No fasting is required. Our trained phlebotomist will verify your identity, explain the procedure, and ensure temperature‑controlled cold‑chain transport immediately after the draw. Service is available daily from 8 AM to 11 PM.
3. Can this test be used for pediatric patients?
Yes, the test is validated for all ages. However, predictive genetic testing in minors requires parental consent and a referral from a clinical geneticist in accordance with UAE regulations.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – All genomic data handled with highest encryption and privacy safeguards.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Ensuring secure electronic health data exchange.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Governing clinical safety and patient consent for diagnostic procedures.
- ISO 9001:2015 Certification – Cert: INT/EGQ/2509DA/3139.
- DHA License – Facility License No. 1143, Dubai Healthcare City.
Clinical & Logistical Metadata
| Test Name | FLNA Gene Sequencing (Otopaladigital Syndrome Type 1) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card blood spot |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full gene coverage |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 59410-4 |
| DHA Facility License & Laboratory Address | DNA Labs UAE – License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians